US STOCKS-Wall St gains with financials; biotechs drop
* Biotechs sell off after Clinton tweet
* Biogen, Gilead biggest drag on the S&P, Nasdaq
* Several Fed officials to speak this week
* Dow up 0.8 pct, S&P up 0.6 pct, Nasdaq down 0.2 pct (Updates to late afternoon, changes byline)
By Caroline Valetkevitch
Sept 21 (Reuters) - U.S. stocks climbed in late Monday afternoon trading, rebounding from losses late last week with from gains Apple and financial shares, but a drop in biotech shares limited the advance.
Shares of biotech companies fell after U.S. Democratic presidential candidate Hillary Clinton said she would announce a plan to stop "price gouging" for specialty drugs.
Biogen fell 5.8 percent to $296.40 and Gilead was down 2.9 percent at $105.25.
The S&P healthcare sector fell 1.35 percent, making it the only S&P sector index in the red. The Nasdaq biotech index slumped 4.3 percent. Continuación...